Abbvie Cdr [Cad Hedged]
1 North Waukegan RoadNorth Chicago IL 60064-6400 USA
P: 847-932-7900
http://www.abbvieinvestor.com
Profile
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
Key Executives
Name | Title |
---|---|
Information not available. |